🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is being done to look at how tucatinib could affect the way othe...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2018-09-17
Trial ID
NCT03723395
Treatments Being Tested
Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Subst...
Status
Completed
Location
Mayo Clinic Florida
Start Date
2021-09-22
Trial ID
NCT04530981
Treatments Being Tested
This is a 17 week, randomized, single center, open-label, parallel-group st...
Status
Unknown
Location
PLA General Hospital
Start Date
2009-01
Trial ID
NCT00832481
Treatments Being Tested
The main purpose of this study is to evaluate the effect of pirtobrutinib (...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2020-11-10
Trial ID
NCT06165146
Treatments Being Tested
This study will assess the effect of AZD5004 on Rosuvastatin, Atorvastatin,...
Status
Completed
Location
Research Site
Start Date
2025-05-06
Trial ID
NCT06948747
Treatments Being Tested
The main purpose of this study is to assess the effect of selpercatinib on ...
Status
Completed
Location
Celerion
Start Date
2019-01-29
Trial ID
NCT05469113
Treatments Being Tested
The purpose of this study is to assess the effect of multiple doses of gana...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-03-09
Trial ID
NCT05236530
The main aim of this study is to find out how several doses of TAK-279 affe...
Status
Completed
Location
Celerion
Start Date
2024-03-29
Trial ID
NCT06290050
Treatments Being Tested
This drug-drug interaction (DDI) study aims to evaluate the impact of pelab...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2026-06-12
Trial ID
NCT07340190
Treatments Being Tested
This study aims to evaluate the effects of rezatapopt on the pharmacokineti...
Status
Recruiting
Location
HealthOne Denver
Start Date
2026-02-04
Trial ID
NCT07372625